Cargando…
Neurological Consequences of SARS-CoV-2 Infection and Concurrence of Treatment-Induced Neuropsychiatric Adverse Events in COVID-19 Patients: Navigating the Uncharted
Severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) binds to the angiotensin-converting enzyme 2 (ACE2) receptor and invade the human cells to cause COVID-19-related pneumonia. Despite an emphasis on respiratory complications, the evidence of neurological manifestations of SARS-CoV-2 infect...
Autores principales: | Borah, Pobitra, Deb, Pran Kishore, Chandrasekaran, Balakumar, Goyal, Manoj, Bansal, Monika, Hussain, Snawar, Shinu, Pottathil, Venugopala, Katharigatta N., Al-Shar’i, Nizar A., Deka, Satyendra, Singh, Vinayak |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Frontiers Media S.A.
2021
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7930836/ https://www.ncbi.nlm.nih.gov/pubmed/33681293 http://dx.doi.org/10.3389/fmolb.2021.627723 |
Ejemplares similares
-
Perspectives on RNA Vaccine Candidates for COVID-19
por: Borah, Pobitra, et al.
Publicado: (2021) -
In vitro anti-TB properties, in silico target validation, molecular docking and dynamics studies of substituted 1,2,4-oxadiazole analogues against Mycobacterium tuberculosis
por: Deb, Pran Kishore, et al.
Publicado: (2021) -
Novel Therapies for the Treatment of Neuropathic Pain: Potential and Pitfalls
por: Shinu, Pottathil, et al.
Publicado: (2022) -
Progress Report: Antimicrobial Drug Discovery in the Resistance Era
por: Shinu, Pottathil, et al.
Publicado: (2022) -
Antitubercular, Cytotoxicity, and Computational Target Validation of Dihydroquinazolinone Derivatives
por: Venugopala, Katharigatta N., et al.
Publicado: (2022)